Search

Lisa V. Cook

Examiner (ID: 13949, Phone: (571)272-0816 , Office: P/1678 )

Most Active Art Unit
1642
Art Unit(s)
1641, 1642, 1678, 1677
Total Applications
1370
Issued Applications
805
Pending Applications
161
Abandoned Applications
418

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18323939 [patent_doc_number] => 20230122067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-20 [patent_title] => REAGENT COMPRISING ANTIBODY FROM WHICH PART OF Fc REGION IS DELETED [patent_app_type] => utility [patent_app_number] => 17/914282 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5244 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914282 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914282
REAGENT COMPRISING ANTIBODY FROM WHICH PART OF Fc REGION IS DELETED Mar 24, 2021 Pending
Array ( [id] => 18265476 [patent_doc_number] => 20230086718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-23 [patent_title] => METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A CANCER [patent_app_type] => utility [patent_app_number] => 17/906273 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15039 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906273 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/906273
METHOD FOR PREDICTING THE SURVIVAL TIME OF A PATIENT SUFFERING FROM A CANCER Mar 18, 2021 Abandoned
Array ( [id] => 16949453 [patent_doc_number] => 20210208144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => MITOCHONDRIAL PROTEASE OMA1 AS A MARKER FOR BREAST CANCER [patent_app_type] => utility [patent_app_number] => 17/188006 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8361 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188006 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188006
MITOCHONDRIAL PROTEASE OMA1 AS A MARKER FOR BREAST CANCER Feb 28, 2021 Abandoned
Array ( [id] => 16993248 [patent_doc_number] => 20210231668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY [patent_app_type] => utility [patent_app_number] => 17/169033 [patent_app_country] => US [patent_app_date] => 2021-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7654 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169033 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169033
KIT AND METHOD FOR DETERMINING PROSTATE CANCER MALIGNANCY Feb 4, 2021 Abandoned
Array ( [id] => 19275498 [patent_doc_number] => 12025621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Atypical hemolytic uremic syndrome (AHUS) biomarker proteins [patent_app_type] => utility [patent_app_number] => 17/161783 [patent_app_country] => US [patent_app_date] => 2021-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 76 [patent_no_of_words] => 42295 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17161783 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/161783
Atypical hemolytic uremic syndrome (AHUS) biomarker proteins Jan 28, 2021 Issued
Array ( [id] => 18421605 [patent_doc_number] => 20230176069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-08 [patent_title] => MITIGATING CONCENTRATION EFFECTS OF ANTIBODY DIGESTION FOR COMPLETE SEQUENCE COVERAGE [patent_app_type] => utility [patent_app_number] => 17/796203 [patent_app_country] => US [patent_app_date] => 2021-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26254 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796203 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/796203
MITIGATING CONCENTRATION EFFECTS OF ANTIBODY DIGESTION FOR COMPLETE SEQUENCE COVERAGE Jan 27, 2021 Pending
Array ( [id] => 18178460 [patent_doc_number] => 20230039189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => POPULATION OF ANTIBODIES COMPRISING HOMOGENEOUS ANTIBODIES EACH HAVING LEFT-RIGHT ASYMMETRIC SUGAR CHAINS, AND METHOD FOR PRODUCING SAME [patent_app_type] => utility [patent_app_number] => 17/758469 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9118 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17758469 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/758469
POPULATION OF ANTIBODIES COMPRISING HOMOGENEOUS ANTIBODIES EACH HAVING LEFT-RIGHT ASYMMETRIC SUGAR CHAINS, AND METHOD FOR PRODUCING SAME Dec 27, 2020 Pending
Array ( [id] => 18243000 [patent_doc_number] => 20230075311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => PROGNOSTIC BIOMARKER OF CANCER [patent_app_type] => utility [patent_app_number] => 17/788632 [patent_app_country] => US [patent_app_date] => 2020-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8868 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788632 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/788632
PROGNOSTIC BIOMARKER OF CANCER Dec 24, 2020 Pending
Array ( [id] => 18484903 [patent_doc_number] => 20230212217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-06 [patent_title] => Method for Purifying Biologically Active Peptide by Using Protein A Affinity Chromatography [patent_app_type] => utility [patent_app_number] => 17/789163 [patent_app_country] => US [patent_app_date] => 2020-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14405 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17789163 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/789163
Method for Purifying Biologically Active Peptide by Using Protein A Affinity Chromatography Dec 23, 2020 Pending
Array ( [id] => 16992299 [patent_doc_number] => 20210230719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/133870 [patent_app_country] => US [patent_app_date] => 2020-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13003 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133870 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/133870
COMPOSITIONS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AND METHODS OF USING SAME Dec 23, 2020 Pending
Array ( [id] => 16807910 [patent_doc_number] => 20210130463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => CHECKPOINT BLOCKADE AND MICROSATELLITE INSTABILITY [patent_app_type] => utility [patent_app_number] => 17/131326 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11275 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131326 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/131326
Checkpoint blockade and microsatellite instability Dec 21, 2020 Issued
Array ( [id] => 17587719 [patent_doc_number] => 11325975 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-10 [patent_title] => Checkpoint blockade and microsatellite instability [patent_app_type] => utility [patent_app_number] => 17/131339 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 11325 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131339 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/131339
Checkpoint blockade and microsatellite instability Dec 21, 2020 Issued
Array ( [id] => 17620181 [patent_doc_number] => 11339219 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-24 [patent_title] => Checkpoint blockade and microsatellite instability [patent_app_type] => utility [patent_app_number] => 17/131328 [patent_app_country] => US [patent_app_date] => 2020-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 11520 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17131328 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/131328
Checkpoint blockade and microsatellite instability Dec 21, 2020 Issued
Array ( [id] => 18582953 [patent_doc_number] => 20230265212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-24 [patent_title] => COMPOSITIONS AND METHODS FOR OOCYTE-SPECIFIC CONTRACEPTION [patent_app_type] => utility [patent_app_number] => 17/787773 [patent_app_country] => US [patent_app_date] => 2020-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27413 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787773 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/787773
COMPOSITIONS AND METHODS FOR OOCYTE-SPECIFIC CONTRACEPTION Dec 20, 2020 Pending
Array ( [id] => 18989012 [patent_doc_number] => 20240060981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => OVARIAN CANCER BIOMARKER DETECTION THROUGH OVARIAN BLOOD SAMPLING [patent_app_type] => utility [patent_app_number] => 17/787868 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20930 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -84 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787868 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/787868
Ovarian cancer biomarker detection through ovarian blood sampling Dec 17, 2020 Issued
Array ( [id] => 19227757 [patent_doc_number] => 12007391 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-11 [patent_title] => Means and methods for determining risk of type-1 diabetes by serum protein biomarkers [patent_app_type] => utility [patent_app_number] => 17/101693 [patent_app_country] => US [patent_app_date] => 2020-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 10286 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17101693 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/101693
Means and methods for determining risk of type-1 diabetes by serum protein biomarkers Nov 22, 2020 Issued
Array ( [id] => 17096917 [patent_doc_number] => 20210284708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1 [patent_app_type] => utility [patent_app_number] => 17/090566 [patent_app_country] => US [patent_app_date] => 2020-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17090566 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/090566
METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1 Nov 4, 2020 Abandoned
Array ( [id] => 16848185 [patent_doc_number] => 20210148930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => Methods of Detecting and Preventing Atopic Allergic Diseases [patent_app_type] => utility [patent_app_number] => 17/078417 [patent_app_country] => US [patent_app_date] => 2020-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6109 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17078417 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/078417
Methods of Detecting and Preventing Atopic Allergic Diseases Oct 22, 2020 Pending
Array ( [id] => 18903955 [patent_doc_number] => 20240019440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => MULTIPLE ANALYTE FECAL ANTIGEN TESTING [patent_app_type] => utility [patent_app_number] => 17/769533 [patent_app_country] => US [patent_app_date] => 2020-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5777 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -54 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/769533
MULTIPLE ANALYTE FECAL ANTIGEN TESTING Oct 15, 2020 Pending
Array ( [id] => 16673161 [patent_doc_number] => 20210061924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-04 [patent_title] => NOVEL ANTI-THYMIDINE KINASE ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/069349 [patent_app_country] => US [patent_app_date] => 2020-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17069349 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/069349
Anti-thymidine kinase antibodies Oct 12, 2020 Issued
Menu